Nomenclature
CAS number: 73573-87-2
rel-
N-[2-Hydroxy-5-[(1
R)-1-hydroxy-2-[[(1
R)-2-(4-methoxyphenyl)-1-methylethyl]amino]ethyl]phenyl]formamide; 3-formylamino-4-hydroxy-α-[
N-[1-methyl-2-(
p-methoxyphenyl)ethyl]aminomethyl]benzyl alcohol; (±)-2′-hydroxy-5′-[
(RS)-1-hydroxy-2-[[(
RS)-
p-methoxy-α-methylphenethyl]amino]ethyl]formanilide.
C
19H
24N
2O
4; mol wt 344.40.
C 66.26%, H 7.02%, N 8.13%, O 18.58%.
Description and references
Selective β2-adrenergic receptor
agonist. Mixture of R,R () and S,S (+) enantiomers.
Prepn: M. Murakami et al., DE 2305092; eidem, US 3994974 (1973, 1976 both to Yamanouchi); K. Murase et al., Chem. Pharm. Bull. 25, 1368 (1977). Absolute configuration and activity of isomers: eidem, ibid. 26, 1123 (1978). Toxicity studies: T. Yoshida et al., Pharmacometrics 26, 811 (1983).
HPLC determn in plasma: J. Campestrini et al., J. Chromatogr. B 704, 221 (1997).
Review of pharmacology: G. P. Anderson, Life Sci. 52, 2145-2160 (1993); and clinical
efficacy: R. A. Bartow, R. N. Brogden, Drugs 55, 303-322 (1998).
Derivative
Fumarate dihydrate.
Nomenclature
CAS number: 43229-80-7
BD-40A; Atock (Yamanouchi); Foradil (Novartis); Oxeze (AstraZeneca).
(C
19H
24N
2O
4)
2.C
4H
4O
4.2H
2O; mol wt 840.91.
C 59.99%, H 6.71%, N 6.66%, O 26.64%.
Properties
Crystals from 95% isopropyl alcohol, mp 138-140°. pKa1 7.9; pKa2 9.2. Log P (octanol/water): 0.4 (pH 7.4). Freely sol in glacial acetic acid; sol in methanol;
sparingly sol in ethanol, isopropanol; slightly sol in water. Practically
insol in acetone, ethyl acetate, diethyl ether. LD50 in male, female, rats, mice (mg/kg): 3130, 5580, 6700, 8310 orally; 98, 100, 72, 71 i.v.; 1000, 1100, 640, 670 s.c.; 170, 210, 240, 210 i.p. (Yoshida).Derivative
R,R-Form.
Nomenclature
CAS number: 67346-49-0
Arformoterol.
Derivative
R,R-Form l-tartrate.
Nomenclature
CAS number: 200815-49-2
Arformoterol tartrate.
C
19H
24N
2O
4.C
4H
6O
6; mol wt 494.49.
C 55.86%, H 6.12%, N 5.67%, O 32.36%.
Description and references
Prepn: Y. Gao et al., WO 9821175; eidem, US 6040344 (1998, 2000 both to Sepracor). Pharmacology:
D. A. Handley et al., Pulm. Pharmacol.
Ther. 15, 135 (2002).
Properties
Off-white powder, mp 184°.Therapeutic Category
Antiasthmatic.
Keywords
β-Adrenergic Agonist; Bronchodilator; Ephedrine Derivatives